PUBLISHER: The Business Research Company | PRODUCT CODE: 1608765
PUBLISHER: The Business Research Company | PRODUCT CODE: 1608765
Longevity And Anti-senescence Therapy Global Market Report 2024
Longevity and anti-senescence therapy encompass medical and scientific strategies aimed at extending human lifespan and promoting healthy aging by targeting the biological processes that contribute to aging, cellular damage, and a decline in bodily functions. These therapies focus on mitigating or reversing senescence, a process in which cells lose their ability to divide and function properly, contributing to aging and age-related diseases.
The primary types of longevity and anti-senescence therapies include senolytic drug therapy, gene therapy, cell therapy, mitochondrial therapy, immunotherapy, and others. Senolytic drug therapy specifically involves the use of medications designed to target and eliminate senescent cells, which have ceased to divide and contribute to aging and age-related diseases. This therapy is applied in areas such as longevity enhancement, senescence inhibition, cardiovascular diseases, neurodegenerative disorders, ophthalmic conditions, and cancer treatment, primarily by hospitals and medical service institutions.
The longevity and anti-senescence therapy market research report is one of a series of new reports from The Business Research Company that provides longevity and anti-senescence therapy market statistics, including longevity and anti-senescence therapy industry global market size, regional shares, competitors with a longevity and anti-senescence therapy market share, detailed longevity and anti-senescence therapy market segments, market trends and opportunities, and any further data you may need to thrive in the longevity and anti-senescence therapy industry. This longevity and anti-senescence therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The longevity and anti-senescence therapy market size has grown strongly in recent years. It will grow from $26.45 billion in 2023 to $28.13 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several factors, including increasing life expectancy, heightened awareness of preventive healthcare, breakthroughs in gene therapy, advancements in regenerative medicine, and an aging global population.
The longevity and anti-senescence therapy market size is expected to see strong growth in the next few years. It will grow to $36.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth during the forecast period is expected to be driven by factors such as the growing demand for personalized medicine, increased investment in AI-powered health diagnostics, rising consumer interest in wellness and anti-aging products, the convergence of nanotechnology with regenerative therapies, and expanding applications of stem cell treatments. Key trends anticipated in this period include the integration of gene editing and stem cell therapies, the expansion of wearable health technology for personalized care, the rising popularity of nutraceuticals for cellular health, advancements in nanomedicine for targeted anti-aging therapies, and the convergence of biotechnology with regenerative medicine.
The rising incidence of cardiovascular diseases is anticipated to drive the growth of the longevity and anti-senescence therapy market in the coming years. The prevalence of cardiovascular diseases is increasing due to various risk factors, including obesity, diabetes, sedentary lifestyles, poor diet, an aging population, and chronic inflammation. Longevity and anti-senescence therapies aim to address cardiovascular disease by targeting age-related cellular damage and enhancing overall heart health. For example, a report from the American College of Cardiology in August 2022 projected that between 2025 and 2060, all four major cardiovascular risk factors in the United States will rise, with diabetes expected to see the largest increase of 39.3%, reaching 55 million individuals. This will be followed by significant increases in dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Therefore, the growing prevalence of cardiovascular diseases is a key driver for the longevity and anti-senescence therapy market.
Prominent companies in the longevity and anti-senescence therapy markets are pursuing strategic partnerships to advance their anti-senescence product offerings. These partnerships are collaborative agreements that enable organizations to leverage each other's strengths and resources to achieve shared objectives and enhance their competitive positions. For instance, in July 2024, MDB Capital Holdings LLC, a US-based investment holding company, formed a partnership with Mayo Clinic, a nonprofit medical and surgical clinic, to enhance its anti-senescence platform. The goal of this collaboration is to develop therapies targeting cellular senescence, which is linked to aging and various diseases. The partnership will utilize Mayo Clinic's clinical research expertise alongside MDB Capital's innovative drug development approach, aiming to improve patient outcomes for age-related conditions. This initiative underscores the increasing focus on addressing the biological mechanisms of aging through advanced therapeutic strategies.
In October 2023, Advantage Therapeutics Inc., a US-based company, acquired the intellectual property portfolio of Klogenix LLC for an undisclosed amount. This acquisition enhances Advantage Therapeutics' capabilities and increases its potential to develop impactful therapies for age-related diseases, thereby significantly improving patient outcomes in this vital healthcare sector. Klogenix LLC is a US-based provider of longevity and anti-senescence therapies.
Major companies operating in the longevity and anti-senescence therapy market are AbbVie Inc., BioAge Labs, Unity Biotechnology, Insilico Medicine, Human Longevity Inc., Calico Life Sciences LLC, Recursion Pharmaceuticals, AgeX Therapeutics Inc., Alkahest Inc., CohBar Inc., Stealth Bio Therapeutics, Altos Labs, Navitor Pharmaceuticals Inc., Sierra Sciences LLC, T.A. Sciences Inc., Juvenescence AI Limited, MDB Capital Holdings LLC, Senex Biotechnology, Spotlight Bioscience, Prana Biotechnology Ltd.
North America was the largest region in the longevity and anti-senescence therapy market in 2023. The regions covered in the longevity and anti-senescence therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the longevity and anti-senescence therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The longevity and anti-senescence therapy market consists of revenues earned by entities by providing services such as biomarker analysis, platelet-rich plasma (PRP) therapy, exosome therapy, bioidentical hormone replacement therapy, and anti-aging skin treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The longevity and anti-senescence therapy market also includes sales of peptide-based products, antioxidant and anti-inflammatory products, cognitive enhancers, and skincare and anti-aging cosmetics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Longevity And Anti-senescence Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on longevity and anti-senescence therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for longevity and anti-senescence therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The longevity and anti-senescence therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Therapy: Senolytic Drug Therapy; Gene Therapy; Cell Therapy; Mitochondrial Therapy; Immunotherapy; Other Therapies
- 2) By Application: Longevity; Senescence Inhibition; Cardiovascular Diseases; Neural Degenerative Diseases; Ophthalmology Disorders; Cancer
- 3) By End User: Hospital; Medical Service Institution
- Companies Mentioned: AbbVie Inc.; BioAge Labs; Unity Biotechnology; Insilico Medicine; Human Longevity Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Longevity And Anti-senescence Therapy Market Characteristics
3. Longevity And Anti-senescence Therapy Market Trends And Strategies
4. Longevity And Anti-senescence Therapy Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Longevity And Anti-senescence Therapy Market Size and Growth
- 5.1. Global Longevity And Anti-senescence Therapy Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Longevity And Anti-senescence Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Longevity And Anti-senescence Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Longevity And Anti-senescence Therapy Market Segmentation
- 6.1. Global Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Senolytic Drug Therapy
- Gene Therapy
- Cell Therapy
- Mitochondrial Therapy
- Immunotherapy
- Other Therapies
- 6.2. Global Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Longevity
- Senescence Inhibition
- Cardiovascular Diseases
- Neural Degenerative Diseases
- Ophthalmology Disorders
- Cancer
- 6.3. Global Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospital
- Medical Service Institution
7. Longevity And Anti-senescence Therapy Market Regional And Country Analysis
- 7.1. Global Longevity And Anti-senescence Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Longevity And Anti-senescence Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Longevity And Anti-senescence Therapy Market
- 8.1. Asia-Pacific Longevity And Anti-senescence Therapy Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Longevity And Anti-senescence Therapy Market
- 9.1. China Longevity And Anti-senescence Therapy Market Overview
- 9.2. China Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Longevity And Anti-senescence Therapy Market
- 10.1. India Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Longevity And Anti-senescence Therapy Market
- 11.1. Japan Longevity And Anti-senescence Therapy Market Overview
- 11.2. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Longevity And Anti-senescence Therapy Market
- 12.1. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Longevity And Anti-senescence Therapy Market
- 13.1. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Longevity And Anti-senescence Therapy Market
- 14.1. South Korea Longevity And Anti-senescence Therapy Market Overview
- 14.2. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Longevity And Anti-senescence Therapy Market
- 15.1. Western Europe Longevity And Anti-senescence Therapy Market Overview
- 15.2. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Longevity And Anti-senescence Therapy Market
- 16.1. UK Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Longevity And Anti-senescence Therapy Market
- 17.1. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Longevity And Anti-senescence Therapy Market
- 18.1. France Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Longevity And Anti-senescence Therapy Market
- 19.1. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Longevity And Anti-senescence Therapy Market
- 20.1. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Longevity And Anti-senescence Therapy Market
- 21.1. Eastern Europe Longevity And Anti-senescence Therapy Market Overview
- 21.2. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Longevity And Anti-senescence Therapy Market
- 22.1. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Longevity And Anti-senescence Therapy Market
- 23.1. North America Longevity And Anti-senescence Therapy Market Overview
- 23.2. North America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Longevity And Anti-senescence Therapy Market
- 24.1. USA Longevity And Anti-senescence Therapy Market Overview
- 24.2. USA Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Longevity And Anti-senescence Therapy Market
- 25.1. Canada Longevity And Anti-senescence Therapy Market Overview
- 25.2. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Longevity And Anti-senescence Therapy Market
- 26.1. South America Longevity And Anti-senescence Therapy Market Overview
- 26.2. South America Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Longevity And Anti-senescence Therapy Market
- 27.1. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Longevity And Anti-senescence Therapy Market
- 28.1. Middle East Longevity And Anti-senescence Therapy Market Overview
- 28.2. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Longevity And Anti-senescence Therapy Market
- 29.1. Africa Longevity And Anti-senescence Therapy Market Overview
- 29.2. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Longevity And Anti-senescence Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Longevity And Anti-senescence Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Longevity And Anti-senescence Therapy Market Competitive Landscape And Company Profiles
- 30.1. Longevity And Anti-senescence Therapy Market Competitive Landscape
- 30.2. Longevity And Anti-senescence Therapy Market Company Profiles
- 30.2.1. AbbVie Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. BioAge Labs
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Unity Biotechnology
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Insilico Medicine
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Human Longevity Inc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. AbbVie Inc.
31. Longevity And Anti-senescence Therapy Market Other Major And Innovative Companies
- 31.1. Calico Life Sciences LLC
- 31.2. Recursion Pharmaceuticals
- 31.3. AgeX Therapeutics Inc.
- 31.4. Alkahest Inc.
- 31.5. CohBar Inc.
- 31.6. Stealth Bio Therapeutics
- 31.7. Altos Labs
- 31.8. Navitor Pharmaceuticals Inc.
- 31.9. Sierra Sciences LLC
- 31.10. T.A. Sciences Inc.
- 31.11. Juvenescence AI Limited
- 31.12. MDB Capital Holdings LLC
- 31.13. Senex Biotechnology
- 31.14. Spotlight Bioscience
- 31.15. Prana Biotechnology Ltd.
32. Global Longevity And Anti-senescence Therapy Market Competitive Benchmarking
33. Global Longevity And Anti-senescence Therapy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Longevity And Anti-senescence Therapy Market
35. Longevity And Anti-senescence Therapy Market Future Outlook and Potential Analysis
- 35.1 Longevity And Anti-senescence Therapy Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Longevity And Anti-senescence Therapy Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Longevity And Anti-senescence Therapy Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
